These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19759318)

  • 21. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
    Atay Z; Bereket A; Haliloglu B; Abali S; Ozdogan T; Altuncu E; Canaff L; Vilaça T; Wong BY; Cole DE; Hendy GN; Turan S
    Bone; 2014 Jul; 64():102-7. PubMed ID: 24735972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diseases associated with the extracellular calcium-sensing receptor.
    Thakker RV
    Cell Calcium; 2004 Mar; 35(3):275-82. PubMed ID: 15200151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residue 826 in the calcium-sensing receptor is implicated in the response to calcium and to R-568 calcimimetic compound.
    Alvarez-Hernández D; González-Suárez I; Fernández-Martín JL; Rodríguez I; Santamaría I; Coto E; Cannata-Andía JB
    Calcif Tissue Int; 2010 Mar; 86(3):227-33. PubMed ID: 20130845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
    Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
    Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene.
    Cole DE; Janicic N; Salisbury SR; Hendy GN
    Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.
    Wystrychowski A; Pidasheva S; Canaff L; Chudek J; Kokot F; Wiecek A; Hendy GN
    J Clin Endocrinol Metab; 2005 Feb; 90(2):864-70. PubMed ID: 15572418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders Caused by Mutations in Calcium-Sensing Receptor and Related Diseases.].
    Michigami T
    Clin Calcium; 2017; 27(4):521-527. PubMed ID: 28336828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-sensing receptor and associated diseases.
    Hendy GN; Guarnieri V; Canaff L
    Prog Mol Biol Transl Sci; 2009; 89():31-95. PubMed ID: 20374733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.
    Zajickova K; Vrbikova J; Canaff L; Pawelek PD; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2616-23. PubMed ID: 17473068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcimimetics and hyperparathyroidism.
    Krebs LJ
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia.
    Nanjo K; Nagai S; Shimizu C; Tajima T; Kondo T; Miyoshi H; Yoshioka N; Koike T
    Endocr J; 2010; 57(9):787-92. PubMed ID: 20697181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel CASR mutation in a Tunisian FHH/NSHPT family associated with a mental retardation.
    Sfar S; Bzéouich AA; Kerkeni E; Bouaziz S; Najjar MF; Chouchane L; Monastiri K
    Mol Biol Rep; 2012 Mar; 39(3):2395-400. PubMed ID: 21667241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcimimetic Use in Familial Hypocalciuric Hypercalcemia-A Perspective in Endocrinology.
    Marx SJ
    J Clin Endocrinol Metab; 2017 Nov; 102(11):3933-3936. PubMed ID: 28945857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
    Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Pollak MR; Brown EM; Chou YH; Hebert SC; Marx SJ; Steinmann B; Levi T; Seidman CE; Seidman JG
    Cell; 1993 Dec; 75(7):1297-303. PubMed ID: 7916660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics.
    Brown EM
    Subcell Biochem; 2007; 45():139-67. PubMed ID: 18193637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis.
    Felderbauer P; Hoffmann P; Klein W; Bulut K; Ansorge N; Epplen JT; Schmitz F; Schmidt WE
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):31-4. PubMed ID: 15662592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.
    Hannan FM; Nesbit MA; Zhang C; Cranston T; Curley AJ; Harding B; Fratter C; Rust N; Christie PT; Turner JJ; Lemos MC; Bowl MR; Bouillon R; Brain C; Bridges N; Burren C; Connell JM; Jung H; Marks E; McCredie D; Mughal Z; Rodda C; Tollefsen S; Brown EM; Yang JJ; Thakker RV
    Hum Mol Genet; 2012 Jun; 21(12):2768-78. PubMed ID: 22422767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.